Pantha develops the Translucid product, a narrowly scoped offering where the observed vulnerability signal centers on cross-site scripting and related input-handling issues in web-facing contexts. Current severity, exploitation, and exposure counts are shown alongside this summary.
The number and severity of CVEs published that impact products developed by Pantha over time
Signals from CVEs in this vendor scope (1 CVEs).
1 CVEs · Highest risk first
| CVE | Published | CVSS | Risk | KEV | Exploit |
|---|---|---|---|---|---|
CVE-2009-2145MEDIUM Multiple cross-site scripting (XSS) vulnerabilities in transLucid 1.75 allow remote attackers to inject arbitrary web script or HTML via the (a) NodeID and (b) action parameters to | Jun 22, 2009 | 4.3 | 21 | NO | YES |
Signals from CVEs in this vendor scope (1 CVEs).
An overview of all social media posts that mention a CVE ID that affects a product developed by Pantha.
Media articles that mention a CVE ID that affects a product developed by Pantha — matched by CVE ID, not by vendor name.